MJP Associates Inc. ADV acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 16,086 shares of the company’s stock, valued at approximately $2,067,000.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Frazier Financial Advisors LLC bought a new stake in shares of Merck KGaA during the second quarter worth $25,000. Addison Advisors LLC acquired a new position in shares of Merck KGaA during the second quarter worth $90,000. Comprehensive Financial Planning Inc. PA bought a new position in shares of Merck KGaA in the 2nd quarter valued at $134,000. Stevens Capital Partners bought a new position in shares of Merck KGaA in the 2nd quarter valued at $220,000. Finally, United Bank bought a new position in shares of Merck KGaA in the 2nd quarter valued at $248,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Trading Down 0.9%
OTCMKTS MKGAF opened at $162.12 on Friday. The company has a market cap of $20.95 billion, a price-to-earnings ratio of 24.75 and a beta of 0.96. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The business’s fifty day moving average is $162.47 and its 200 day moving average is $148.35.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
